Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3Completed 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia 8Lymphoma 4Lymphoma, Extranodal NK-T-Cell 3Leukemia, Biphenotypic, Acute 2Recurrence 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

pegaspargase 14Etoposide 11Dexamethasone 11Gemcitabine 10spartalizumab 6Oxaliplatin 4sintilimab 3Radiotherapy 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Methotrexate 3Asparaginase 3tislelizumab 2camrelizumab 2Lenalidomide 2Drug Therapy 2Cyclophosphamide 2Cisplatin 2Busulfan 2Azacitidine 2toripalimab 1tofacitinib 1ruxolitinib 1romidepsin 1pembrolizumab 1fludarabine phosphate 1avelumab 1apatinib 1Thalidomide 1Sensitivity and Specificity 1Psychiatric Rehabilitation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Extranodal NK-T-Cell × Asparaginase × Clear all
NCT02544425 2020-10-22

VIDL+ASCT

Samsung Medical Center

Phase 2 Unknown
27 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT02080234 2016-04-20

Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT00933673 2012-02-20

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma

Fudan University

Phase 2 Unknown
76 enrolled
Lymphoid

Lymphoma, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡